发明名称 |
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND THE METHOD FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE USING THE SAME |
摘要 |
The present invention provides a pharmaceutical composition for the prevention and treatment of a non-alcoholic fatty liver disease (NAFLD), containing an active ingredient selected from the group consisting of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof. Further, the present invention provides a method for the prevention or treatment of a non-alcoholic fatty liver disease, including administering an effective amount of an active ingredient selected from the group consisting of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof to a mammal including a human in need thereof. Further, the present invention provides use of Compound 1 represented by formula 1, sitagliptin, vildagliptin, linagliptin or a pharmaceutically acceptable salt thereof, for manufacturing a pharmaceutical composition for the prevention or treatment of a non-alcoholic fatty liver disease. |
申请公布号 |
EP2549997(A2) |
申请公布日期 |
2013.01.30 |
申请号 |
EP20110759725 |
申请日期 |
2011.03.23 |
申请人 |
DONG-A PHARM.CO., LTD. |
发明人 |
AN, GOOK-JUN;YANG, EUN-KYOUNG;CHO, EUN-JUNG;CHAE, YU-NA;CHOI, SONG-HYEN;KIM, HA-DONG;SHIN, CHANG-YELL;KIM, MI-KYUNG;KWAK, WOO-YOUNG;KIM, HEUNG-JAE;SON, MOON-HO;KIM, SOON-HOE |
分类号 |
A61K31/496;A61K31/401;A61P1/00;A61P1/16 |
主分类号 |
A61K31/496 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|